Aronow W S
Hebrew Hospital Home, Mount Sinai School of Medicine, New York, NY, USA.
Compr Ther. 1998 Jun-Jul;24(6-7):327-31.
Patients (especially older patients) with acute myocardial infarction (MI) treated with or without thrombolytic therapy, who have no contraindications to beta-blockers, should be treated with early intravenous beta-blockade. High-risk subgroups of patients after MI are most likely to benefit from the use of beta-blockers after MI.
对于接受或未接受溶栓治疗的急性心肌梗死(MI)患者(尤其是老年患者),若没有使用β受体阻滞剂的禁忌证,应尽早进行静脉β受体阻滞剂治疗。心肌梗死后的高危亚组患者最有可能从心肌梗死后使用β受体阻滞剂中获益。